Bayer offers biotech capabilities to clients
For the first time, German chemicals and pharmaceuticals major Bayer is offering a range of products and services from its biotechnology division to third-party customers
For the first time, German chemicals and pharmaceuticals major Bayer is offering a range of products and services from its biotechnology division to third-party customers
The market for cell culture products is getting a lift from stringent regulations from the US FDA and Department of Agriculture, restricting the importation and usage of foetal bovine serum
There is a growing trend towards patients self-medicating with over-the-counter products rather than asking their doctors for a prescription medication, and this promises to benefit companies involved in pharmaceutical packaging, says Iggesund Paperboard
Brookfield has introduced the YR-1 Rheometer, designed to provide a simple to operate, low-cost alternative to full-featured laboratory rheometers for quality control applications
The resurgence of merger and acquisition activity in the biotech industry shows little sign of letting up, with US companies IDEC Pharmaceuticals and Biogen the latest to step up to the altar
Centocor forged a deal with Biolex in which the latter firm will examine the feasibility of producing three therapeutic proteins using a proprietary plant-based expression system